Mnemo Therapeutics
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $63M
Investors
- 5
About Mnemo Therapeutics
Founded in 2019 and based in Paris, France, Mnemo Therapeutics is a biotechnology company that focuses on the development of cell therapies. Mnemo Therapeutics uses the EnfiniT platform, a drug discovery engine that integrates cell therapy through the identification of antigens classes.
Who invested in Mnemo Therapeutics
5 investors across 2 rounds
See all investors in Mnemo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mnemo Therapeutics
Who invested in Mnemo Therapeutics?
Mnemo Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mnemo Therapeutics raised?
Mnemo Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mnemo Therapeutics last raise money?
Mnemo Therapeutics's most recent round on record is a Series A, in Feb 2021.
What does Mnemo Therapeutics do?
Founded in 2019 and based in Paris, France, Mnemo Therapeutics is a biotechnology company that focuses on the development of cell therapies.
Where is Mnemo Therapeutics headquartered?
Mnemo Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like Mnemo Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Mnemo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mnemo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.